https://www.avient.com/sites/default/files/2022-10/Omnicolor Case Study Plastic Molder.pdf
PLASTIC INJECTION MOLDER V A R I O U S M A R K E T S & A P P L I C A T I O N
S • Ability to use a color concentrate in multiple resins • Low let down ratio
https://www.avient.com/sites/default/files/2022-01/Dynaflex-Disposable syringe tip cap-Application snapshot.pdf
SYRINGE MANUFACTURING D I S P O S A B L E S Y R I N G E T I P C A P • Excellent
https://www.avient.com/sites/default/files/2024-08/Versollan TPE-Compression Controller - Case study snapshot.pdf
AVIENT SOLUTION MEDICAL DEVICE MANUFACTURER C O M P R E S S I O N C O N T R
O L L E R H O U S I N G G R I P • Good adhesion to PCTG • Comfortable grip combined
https://www.avient.com/sites/default/files/2021-06/cp204a-ya-2021-avient.pdf
KEPONG UTARA, 52100 KUALA LUMPUR WP KUALA LUMPUR A V I E N T C O L O R A N T S
M A L A Y S I A S D N .
https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-nymax-pir-marine-accessories.pdf
OUTDOOR HIGH PERFORMANCE MANUFACTURER M A R I N E A C C E S S O R I E S • High
https://www.avient.com/sites/default/files/2023-03/AVNT Mar 2023 Earnings Presentation.pdf
PowerPoint - AVNT Mar 2023 Earnings Presentation AVIENT CORPORATION I N V E S
T O R P R E S E N T A T I O N (NYSE: AVNT) M A R C H 2 0 2 3 DISCLAIMER Forward-Looking
O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Presentation.pdf
Earnings Presentation AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 2 R E S
U L T S A N D 2 0 2 3 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R
O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
INVESTMENT IN COMMERCIAL RESOURCES D R I V E S I N N O VAT I V E P R O D U C
T P O R T F O L I O AN D S AL E S G R O W T H 19 160 270 2011 2019 2020E 0.16
A L E S BY END MARKET (58% of sales) (25% of sales) (17% of sales) 27
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
AVIENT CORPORATION (NYSE: AVNT) M A R C H 1 8 , 2 0 2 1 I R M E E T I N G S
H O S T E D B Y F E R M I U M R E S E A R C H DISCLAIMER 2 Forward-Looking Statements
A L E S BY END MARKET (58% of sales) (26% of sales) (16% of sales) 33
https://www.avient.com/sites/default/files/2022-05/AVNT May IR Presentation w Non GAAP Recs.pdf
NYSE: AVNT) AVIENT CORPORATION I N V E S T O R M E E T I N G S M AY 2 0 2 2
U S T A I N A B I L I T Y G O A L S PRODUCTS AVIENT’S EXISTING COMPOSITES PORTFOLIO
D I V E R S E C A P A B I L I T I E S A N D S O L U T I O N S S E R V I N G